Profile: Kedem Pharmaceuticals Inc (KDMP.PK)

KDMP.PK on OTC Markets Group - US Other OTC and Grey Market

19 Sep 2014
Price Change (% chg)

$-0.00 (-50.00%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Kedem Pharmaceuticals Inc., formerly Global Health Ventures Inc., incorporated on April 25, 2006, is a development stage specialty pharmaceutical company engaged in developing platform technology that delivers drugs via the sublingual (under the tongue) route. The Company is also developing oral formulations of drugs, which are focused to cause fewer stomach side effects than formulations of such drugs. Its lifestyle products are related to male sexual enhancement, anti-addiction and energy boosters. The Company's therapeutic products are related to weight loss and pulmonary disease management. The Company's portfolio of products includes X-Excite (male sexual enhancement drug); Relax-B (anti-stress drug); Nico-Z (nicotine replacement product); V-Energy (energy booster product), and T-Slim (appetite suppressor drug).


X-Excite is a development stage sublingual formulation of sildenafil. Sildenafil is registered under the trade name of Viagra and is marketed by Pfizer Relax-B.


Relax-B product utilizes propranolol as its active ingredient. It has formulated propranolol to absorb sublingually and have used tastes masking products to reduce the taste.


Nico-Z is a sublingual formulation of nicotine designed for cigarette replacement. The Company is using a small dose of nicotine (about 5 times less than commercial nicotine). Nico-Z is not designed for smoking cessation.


This product is a sublingual formulation of vitamin B6/B12. Vitamin B6/B12 is a stimulus and anti-tiredness compound. Vitamin B6/B12 is often used in cancer patients to help them be less tired and more energetic.


T-Slim are a formulation of catechin. Catechin is a flavonoid that is found in higher plants and green tea. Catechin is a component in reducing appetite but has a poor oral absorption rate.

Company Address

Kedem Pharmaceuticals Inc

Suite 1023, 409 Granville Street
P: +1604.3244844

Company Web Links

Search Stocks